z-logo
open-access-imgOpen Access
Recommendations for the Treatment of Parkinson's Disease
Author(s) -
Cori Gray,
Craig Stern
Publication year - 2018
Publication title -
journal of contemporary pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2573-2765
pISSN - 2573-2757
DOI - 10.37901/jcphp16-00031
Subject(s) - substantia nigra , dopamine , neuroscience , parkinson's disease , pathological , disease , medicine , psychology , dopaminergic , pathology
Parkinson's disease is a progressive disorder of the nervous system characterized by trembling or shaking of a limb, rigidity or stiffness of limbs, an inability to move, and impaired balance and coordination. Most symptoms begin to occur when neurons that produce dopamine in the substantia nigra of our brain die or become impaired. Dopamine is a chemical messenger that sends signals to our brain to produce smooth muscle movements. Without the neurons that create dopamine, our brain becomes unable to produce these muscle movements. Another pathological feature is the appearance of intracytoplasmic inclusions (Lewy bodies) in the remaining, intact nigral neurons.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom